Page 1246 - Small Animal Clinical Nutrition 5th Edition
P. 1246

1298 SMALL ANIMAL CLINICAL NUTRITION


                    avoiding excesses in renal patients, 788-789        nutritional composition in cats, 418-419, 419t, 421, 422t
                    requirements and excesses, 108t                     nutritional composition in dogs, 298-299, 303
                  Chocolate, toxicity of, 230t, 235-236               Commercial pet foods, 157-190
        VetBooks.ir  Cholangitis/cholangiohepatitis, in cats, 1144, 1145t, 1147,  Compliance, 18, 31-42
                                                                        adverse reactions to food, 625
                    1157t, 1159, 1163, 1165, 1170-1171, 1179-1180
                  Cholecalciferol (See Vitamin D)                       canine urolithiasis, dissolution/prevention, 831b, 841t, 845,
                  Cholesterol (See Hypercholesterolemia)                846t, 849, 861, 864t, 866t, 884t, 886t, 897t, 903t
                  Choline, function and metabolism, 124t, 137-138       chronic kidney disease, 786b
                  canine blood levels, 132t                             client, 37-39
                    feline blood levels, 132t                           definitions of, 38-39
                  Chromium, 108t, 122                                   effects of nutrients on drug absorption, 1196t
                  Chronic kidney disease, 765-810                       endocrine disorders, 557
                    assessment of animals with, 768-781                 FLUTD, 964t, 965
                    causes, 766-768                                     homemade foods, 213-214, 218
                    clinical importance of, 766-768                     impact of health literacy on, 37
                    commercial products for management of, 796t, 797t   inflammatory bowel disease, 1074
                    distinguishing between acute and chronic kidney disease,  osteoarthritis, 703, 708b
                    774t                                                periodontal disease, role in, 979, 980b, 991, 994
                    etiopathogenesis of, 774-775                        persistent hyperlipidemia, 553-555
                    evidence for treatment, 782t                        pharyngeal/esophageal disorders, 1021
                    feeding plan for animals with, 795-799              skin and hair disorders, 651
                    key nutritional factors for, 781-793, 781t          weight-loss programs, 504b, 520b, 531b
                    maintenance of lean body mass, 787b               Compound uroliths, in dogs (See also Canine compound
                    nutrient-drug interactions in animals with, 751-753  urolithiasis) 816t, 828t, 829t
                    phosphorus levels and progression, 776-777, 777f, 783b,  Congestive heart failure (See Heart disease/failure)
                    785-788                                           Constipation/obstipation/megacolon, 1117-1126, 1125-1126c
                    protein levels in, 781t, 782-785, 783b              adjunctive medical therapy, 1123
                    reassessment methods, 799                           algorithm for combined dietary and medical management
                    relationship to aging, 766                          of, 1123f
                    summary of studies, 786b                            assessment of, 1117-1121
                    tips for encouraging food acceptance, 798b          clinical importance of, 1117
                  Chronic renal failure (See Chronic kidney disease)    dietary management of perianal fistulas in dogs, 1119b
                  Chylomicrons, 82, 98, 100, 100f, 483, 546f, 548-553, 556c,  drugs associated with, 1118t
                    1078-1079, 1080b, 1147, 1150                        feeding plan for patients with, 1121-1123
                  Chylomicron test, 548, 549f, 554                      key nutritional factors for, 1120-1121, 1120t, 1122t
                  Cirrhosis, 233, 247-249c, 838, 1156, 1157t, 1159f, 1162-  risk factors for, 1118
                    1166, 1165b, 1171, 1188-1189c                       supplemental fiber, 1121b
                  Citrate, use in urolithiasis, 841t, 844, 860, 863, 864t, 866,  Copper, 108t, 119-120
                    866t, 868-870c                                      association with liver disease, 1157t, 1161, 1161f, 1188-
                  Claims, dental claims for foods/treats, 163b, 981, 986-987,  1189c, 1190-1192c
                    987b, 993-994, 994b                                 chelating agents, 1172b, 1174f
                  Clostridium botulinum, 184, 232, 237                  content of selected foods, 1173b, 1178t
                  Cobalamin, 123, 124t, 1070, 1074, 1086, 1088-1089, 1094,  deficiency, 108t, 372b, 418f
                    1138, 1140, 1141-1142c                                relationship to developmental orthopedic disease of dogs,
                    canine blood levels, 132t                             680
                    feline blood levels, 132t                             relationship to skin and hair disorders, 638t, 645-646
                    function, metabolism and sources of, 137            normal levels in liver, 1162
                  Cobalt, 107, 137                                      oxide and poor availability, 119
                  Cognitive dysfunction in dogs, 715-730                recommended levels in copper hepatotoxicosis, 1162, 1178
                    adjunctive therapy, 725-726                         requirement, of reproducing cats, 119-120, 142-143c, 408
                    assessment of, 715-723                              requirement of reproducing dogs, 290
                    clinical importance of, 715                         requirements and deficiencies, 119
                    commercial foods for, 725t                        Copper-associated hepatotoxicosis, in dogs, 1162-1163, 1173,
                    drugs therapy, 726                                  1174f, 1175, 1188-1189c, 1190-1192c
                    etiopathogenesis, 719-723                           key nutritional factors for, 1170t, 1178t
                    feeding plan for patients with, 725-726             use of copper chelating agents for, 1174, 1174f
                    key nutritional factors for, 723-725, 723t        Coprophagia
                    risk factors for, 718-179                           in cats, 364b
                  Cold weather, energy needs for, 260                   in dogs, 269-270b
                  Colitis (See Large bowel diarrhea: Colitis)         Cori cycle, 53, 330
                  Colostrum (See also Milk) 298-299, 301, 304, 304t, 403,  Corn, 68, 89t, 90t, 91t, 94t, 95, 173b, 174t, 217t, 858t, 917
                    406b, 418-419, 419t, 421, 422t                    Corn gluten feed, 917-918, 918t, 920t
   1241   1242   1243   1244   1245   1246   1247   1248   1249   1250   1251